ETCs counting in combination with SHOX2 and RASSF1A methylation assays in BALF has shown to be highly efficient in lung cancer diagnosis and is an effective complementary tool for clinical diagnosis of lung cancer. The gene discussed is SHOX2; the disease is lung carcinoma.